12
May 2026
Implantable cytokine factories show promise against advanced ovarian cancer
Implantable cytokine factories designed to deliver immunotherapy directly at the site of disease have taken an important step toward clinical reality.
Stay Informed!
12
May 2026
Researchers uncover nuclear organization mechanism linked to Friedreich's ataxia
Researchers have uncovered a fundamental rule that governs how genes are physically arranged inside the cell nucleus, and how disruptions to that organization can contribute to human disease.
12
May 2026
Home-based assessments may detect early mobility risks
Predicting whether a healthy 45-year-old will struggle to climb stairs or walk a decade later has long been a challenge for geriatric medicine.
12
May 2026
Dual-pathway protein degradation approach could improve cancer treatment
Targeted protein degradation has become one of the most promising strategies in modern drug discovery, enabling scientists to eliminate disease-causing proteins instead of merely blocking them.
12
May 2026
Large human islet study reveals new insights into diabetes risk
Diabetes is the most common and serious chronic disease worldwide, characterized by insufficient insulin to maintain proper blood glucose levels.
12
May 2026
Loss of X chromosome linked to female infertility risk
Chromosomes carry genetic information for biological sex, which generally assigns women two X chromosomes and men XY chromosomes.
12
May 2026
Interactive AI model improves explainable lung cancer diagnosis from CT scans
Lung cancer remains one of the leading causes of cancer-related deaths worldwide, making early and accurate diagnosis essential for improving patient outcomes.
12
May 2026
Could GLP-1 drugs help breast cancer patients live longer?
A large retrospective cohort study of adult female breast cancer patients found that GLP-1 receptor agonist use was associated with better all-cause survival and recurrence-free survival in patients with obesity or type 2 diabetes. The strongest associations were seen versus non-use in obesity and versus insulin or metformin in type 2 diabetes, while comparisons with SGLT2 inhibitors were less consistent and require further study.
12
May 2026
Why is the US falling behind other high-income nations on survival?
A JAMA Network Open study found that the US recorded 12.7 million excess deaths compared with 17 peer high-income countries between 1999 and 2022. Circulatory and metabolic diseases drove much of the burden, while drug poisonings, alcohol-related deaths, and suicide sharply widened the gap among younger Americans.
12
May 2026
How diabetes could drain $5 trillion from the global economy by 2050
A macroeconomic modelling study across 190 countries and territories estimates that diabetes could reduce global economic output by INT$5.177 trillion between 2021 and 2050. Most projected losses stem from diabetes-related disability and morbidity, with high-income countries facing the largest dollar losses and low- and middle-income countries carrying most of the disease burden.
